~104 spots leftby Jun 2026

Enhanced Diabetes Management Program for Type 2 Diabetes

(FREEDOM Trial)

Recruiting at1 trial location
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of Alabama at Birmingham
Must be taking: Insulin, HIV ART
Disqualifiers: Cognitive impairment, End-stage kidney disease, others
No Placebo Group
Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

Brief Summary: The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adults in the Deep South. The intervention targets social determinants of health (SDoH) such as reduced healthcare access, poverty, transportation barriers, and food insecurity.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, ongoing insulin treatment is required, and if you are part of the HIV cohort, you must continue your prescribed HIV ART therapy.

What data supports the effectiveness of this treatment for managing Type 2 Diabetes?

Research shows that diabetes self-management education and support (DSMES) programs can improve health outcomes, such as reducing weight and blood sugar levels, and decrease emergency visits. Digital tools and community-based programs have been effective in extending these benefits and supporting lifestyle changes.12345

Is the Enhanced Diabetes Management Program for Type 2 Diabetes safe for humans?

The Diabetes Self-Management Education and Support (DSMES) programs, which are part of the Enhanced Diabetes Management Program, have been shown to improve health outcomes and reduce emergency visits, indicating they are generally safe for humans.34678

How is the Enhanced Diabetes Management Program for Type 2 Diabetes different from other treatments?

The Enhanced Diabetes Management Program is unique because it combines Diabetes Self-Management Education and Support (DSMES) with digital health coaching, food box delivery, and remote patient monitoring (RPM), offering a comprehensive approach that integrates education, nutrition, and technology to support patients in managing their diabetes more effectively.357910

Research Team

Eligibility Criteria

The FREEDOM study is for low-income Black adults in the Deep South with type 2 diabetes, aged 18 or older, who are HIV positive and on insulin treatment. Participants must have a high HbA1c level indicating poor blood sugar control and face social challenges like poverty. They can't join if they're pregnant, planning to become pregnant soon, have severe kidney disease or cognitive issues, or are already in another diabetes study.

Inclusion Criteria

I am on HIV medication as part of my treatment.
I have been diagnosed with HIV.
Self-identified as Black/African American
See 8 more

Exclusion Criteria

I am not currently enrolled in any diabetes-related study or lifestyle program.
I joined a remote patient monitoring or health coaching program, excluding smoking cessation, within the last 60 days.
Current enrollment in any diabetes-related interventional study
See 5 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive digital health coaching, food box delivery, and remote patient monitoring for diabetes management

12 months
3 in-person visits (baseline, month 6, month 12), 2 telephone check-ins (month 3, month 9)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Core Intervention: Diabetes Self-Management Education and Support (DSMES) Program (Behavioral Intervention)
  • Digital Health Coaching (Behavioral Intervention)
  • Food Box Delivery (Dietary Supplement)
  • Remote Patient Monitoring (RPM) (Behavioral Intervention)
Trial OverviewThis trial tests a comprehensive approach to manage type 2 diabetes by providing participants with food deliveries tailored to their dietary needs, digital health coaching sessions for better disease understanding and management strategies, remote patient monitoring tools to track health metrics regularly from home, and specialized education classes about diabetes care.
Participant Groups
8Treatment groups
Experimental Treatment
Active Control
Group I: Arm 1Experimental Treatment4 Interventions
Digital coaching+ Food delivery+ RPM
Group II: Arm 4Active Control3 Interventions
Digital coaching+ RPM
Group III: Arm 5Active Control3 Interventions
Food delivery+ RPM
Group IV: Arm 6Active Control1 Intervention
The participant's will not receive any Intervention
Group V: Arm 8Active Control2 Interventions
RPM
Group VI: Arm 2Active Control2 Interventions
Digital coaching
Group VII: Arm 3Active Control3 Interventions
Digital coaching+ Food delivery
Group VIII: Arm 7Active Control2 Interventions
Food delivery

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+
Kierstin Kennedy profile image

Kierstin Kennedy

University of Alabama at Birmingham

Chief Medical Officer since 2022

MD

S. Dawn Bulgarella profile image

S. Dawn Bulgarella

University of Alabama at Birmingham

Chief Executive Officer since 2023

BSc in Commerce and Business Administration from the University of Alabama, MS in Health Administration from the University of Alabama at Birmingham

Cooper Green Mercy Health Services

Collaborator

Trials
1
Recruited
300+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+
Dr. Eliseo J. Pérez-Stable profile image

Dr. Eliseo J. Pérez-Stable

National Institute on Minority Health and Health Disparities (NIMHD)

Chief Executive Officer since 2015

MD from University of Miami

Dr. Rada Dagher profile image

Dr. Rada Dagher

National Institute on Minority Health and Health Disparities (NIMHD)

Chief Medical Officer since 2024

MD from University of California, San Francisco

Pack Health

Industry Sponsor

Trials
6
Recruited
1,100+

University of Mississippi Medical Center

Collaborator

Trials
185
Recruited
200,000+
Dodie T. McElmurray profile image

Dodie T. McElmurray

University of Mississippi Medical Center

Chief Executive Officer since 2024

BS in Nursing from Delta State University, MSN/MBA from University of Phoenix

Dr. LouAnn Woodward profile image

Dr. LouAnn Woodward

University of Mississippi Medical Center

Chief Medical Officer since 2015

MD from University of Mississippi Medical Center

Cooper Green Mercy Health Systems

Collaborator

Trials
1
Recruited
300+

Findings from Research

Implementing diabetes self-management education (DSME) in primary care clinics (PCCs) significantly increased enrollment in classes and led to notable reductions in A1C levels and weight among participants, particularly those newly diagnosed with diabetes.
The study demonstrated that translating an accredited DSME program from an academic medical center to PCCs effectively improved access to diabetes education, benefiting patients who may not have access to hospital-based programs.
Enhancing Access to Diabetes Self-management Education in Primary Care.Chomko, ME., Odegard, PS., Evert, AB.[2022]
Diabetes self-management education and support (DSMES) is crucial for people with diabetes, as it equips them with the necessary skills and knowledge to manage their condition effectively, leading to improved health outcomes.
The article highlights recent findings from the National Diabetes Education Program National Diabetes Survey, which identifies gaps in self-management behaviors and DSMES delivery, suggesting areas for improvement to enhance diabetes care.
Insights From the National Diabetes Education Program National Diabetes Survey: Opportunities for Diabetes Self-Management Education and Support.Piccinino, LJ., Devchand, R., Gallivan, J., et al.[2020]
A 12-month community-based diabetes self-management education and support program significantly improved health outcomes for 115 participants, including reductions in weight, BMI, and A1C levels, which were sustained over time.
The program also led to a decrease in medication intake and diabetes-related emergency department visits, indicating not only improved health but also potential cost savings in healthcare delivery.
Patient Engagement in Type 2 Diabetes: A Collaborative Community Health Initiative.Freeman, K., Hanlon, M., Denslow, S., et al.[2022]

References

Enhancing Access to Diabetes Self-management Education in Primary Care. [2022]
Early Insights From a Digitally Enhanced Diabetes Self-Management Education and Support Program: Single-Arm Nonrandomized Trial. [2021]
Insights From the National Diabetes Education Program National Diabetes Survey: Opportunities for Diabetes Self-Management Education and Support. [2020]
Patient Engagement in Type 2 Diabetes: A Collaborative Community Health Initiative. [2022]
Mobile Applications to Support Diabetes Self-Management Education: Patient Experiences and Provider Perspectives. [2023]
A Telehealth Diabetes Intervention for Rural Populations: Protocol for a Randomized Controlled Trial. [2022]
Overcoming the struggle of living with type 2 diabetes - diabetes specialist nurses' and patients' perspectives on digital interventions. [2023]
The effect of peer support in diabetes self-management education on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis. [2022]
Capacity of diabetes education programs to provide both diabetes self-management education and to implement diabetes prevention services. [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
Improving Glycemic Control and Quality of Life With Diabetes Self-Management Education: A Pilot Project. [2021]